Insmed Incorporated (INSM) Financials

INSM Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 1.3 billion 1.7 billion
2023-09-30 1.3 billion 1.6 billion
2023-06-30 1.4 billion 1.6 billion
2023-03-31 1.5 billion 1.6 billion

INSM Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -133.0 million 20.0 million
2023-09-30 -139.2 million 20.0 million
2023-06-30 -127.7 million 18.4 million
2023-03-31 -149.7 million 16.4 million

INSM Net Income

No data available :(

INSM Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 780.4 million - 48.7 million
2023-09-30 786.0 million - 49.7 million
2023-06-30 917.8 million 1.1 billion 47.8 million
2023-03-31 998.7 million 1.1 billion 52.5 million

INSM Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 140.4 million
2023-09-30 142.9 million
2023-06-30 137.6 million
2023-03-31 136.4 million

INSM Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 2.2 million 137.0 million 89.5 million -
2023-09-30 2.9 million 109.1 million 90.6 million -
2023-06-30 4.9 million 197.0 million 84.4 million -
2023-03-31 3.4 million 127.9 million 79.9 million -

INSM Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 83.7 million 18.4 million
2023-09-30 79.1 million 16.7 million
2023-06-30 77.2 million 16.6 million
2023-03-31 65.2 million 13.8 million

INSM

Price: $25.55

52 week price:
16.81
32.00

Earnings Per Share: -5.34 USD

P/E Ratio: -5.48

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 1.3 million

Ebitda: -42.9 million

Market Capitalization: 4.0 billion

Links: